1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. FDA Oncology Center of Excellence Presents Conversations on Cancer: “Empowered Choices: Perspectives on Cancer Care Decision-Making Among Older Adults” - 12/11/2025
  1. FDA Meetings, Conferences and Workshops

Webcast | Virtual

Event Title
FDA Oncology Center of Excellence Presents Conversations on Cancer: “Empowered Choices: Perspectives on Cancer Care Decision-Making Among Older Adults”
December 11, 2025


Date:
December 11, 2025
Time:
11:00 a.m. - 12:00 p.m. ET
Organized By:

Image
Conversations on Cancer Empowered Choices1920x1080

X (formerly Twitter): #ConversationsonCancer 

Sponsored by the U.S. Food & Drug Administration (FDA)

Background: 

As the global population ages, healthcare providers increasingly encounter unique challenges in tailoring cancer treatments for older patients. The landscape of cancer care for older adults is complex and multifaceted. It's where personal values and life experiences intersect with medical expertise and technological capabilities.  The session will explore this intricate tapestry of decision-making in geriatric oncology, emphasizing patient-centered decision-making processes.

Crucially, we'll also examine how these decisions impact clinical trial enrollment. Historically, older adults have been underrepresented in cancer clinical trials, limiting our understanding of how new treatments affect this population. Learning about their barriers to care and the decision-making process could inform initiatives to improve access to trials, support pragmatic trial designs and understand the impact of cancer on individual patients.

Webcast Information: 

A free-of-charge webcast of this program can be viewed on Thursday, December 11, 2025, beginning at 11:00 am EST on YouTube at: https://youtube.com/live/vW7_8Az5AzQ

FDA also plans to post a webcast of this Conversations on Cancer program on YouTube for on-demand viewing at: https://www.youtube.com/@US_FDA/videos

Contact:

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

Back to Top